BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 14, 2004
View Archived Issues
Simultaneous targeting of tumor proliferation and angiogenesis shows promising results in vivo
Read More
Erbitux in phase III for NSCLC
Read More
Interim results of BrachySil phase IIa study in liver cancer patients
Read More
Yondelis receives orphan drug status for soft tissue sarcoma
Read More
Peninsula completes phase I study for PPI-0903
Read More
Cand5 enters phase I study for AMD
Read More
BDC-03 under development for cachexia
Read More
Positive phase II results for cetrorelix in BPH
Read More
Diamyd studied in type 2 diabetes patients in Sweden
Read More
Phase III Inactine acute study cleared to continue
Read More
Celltech researchers claim anti-IL-1beta antibodies and their use
Read More
Novel gastric antisecretory agents discovered at Altana
Read More
New NO-releasing COX inhibitors in early development at Altana
Read More
New MIF inhibitors prepared and tested at Avanir
Read More
AstraZeneca team presents new P2X7 antagonists
Read More
Aventis scientists design inhibitors of fungal CIV1 and other kinases
Read More
Three novel series of pyridine-based immunosuppressants developed at AstraZeneca
Read More
No FDA approval for Exanta
Read More
Norditropin NordiFlex receives FDA approval
Read More
In vivo tumor growth inhibition and apoptosis induced by human agonistic TRAIL receptor 2 antibody
Read More
Novel prophylactic and therapeutic HPV vaccine approach
Read More
Antibody therapy promising against C. difficile
Read More
Progress in development and testing of recombinant hookworm vaccine
Read More
Orally active cathepsin K inhibitor prevents bone loss in vitro and in vivo
Read More
ArTec prepares to review preclinical application for Tubercin with FDA
Read More
Allergan and Peplin discontinue PEP-005 collaboration
Read More
Neoprobe updates RIGScan CR and Lymphoseek programs
Read More
Initiation of MERLIN TIMI-36 study of Ranexa
Read More
Provecta IND cleared
Read More
Nabi begins a new clinical trial with PhosLo in ESRD
Read More
Ursodeoxycholate boosts chemoprotective efficacy of sulindac
Read More